» Articles » PMID: 39617704

Untargeted Serum Metabonomic Reveals Alleviated Ovalbumin-induced Asthma by Baijin Pingchuan Through Primary Bile Acid Biosynthesis

Overview
Date 2024 Dec 1
PMID 39617704
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To investigate the effect of baijinpingchuan (, BJPC) on the asthma rat model and identify differential metabolites and disturbed metabolic pathways.

Methods: The rats were categorized into six groups: control, dexamethasone (DEX), ovalbumin (OVA), and low-, median-, and high-dose BJPC. The rats, except for the control group, were initially treated with OVA to develop the asthma model, which was then activated using DEX, OVA, and low-, median-, and high-dose BJPC. Enzyme-linked immunosorbent assay kit was used to detect the expression of interleukin (IL)-33, IL-25, thymic stromal lymphopoietin (TSLP), and transforming growth factor-beta 1 (TGF-β1). Hematoxylin and eosin staining were performed to observe the pathological condition of the lung. Untargeted serum metabonomic analysis was conducted to identify differential metabolites and disturbed metabolic pathways.

Results: High-dose BJPC significantly inhibited the expression of IL-33, IL-25, TSLP, and TGF-β1 ( 0.0001). Further, high-dose BJPC improved inflammatory cell infiltration, which plays a similar role in asthma as DEX. OVA-induced and BJPC-treated rats were identified through 17 differential metabolites, especially cholic acid. Furthermore, primary bile acid biosynthesis was a significantly differential pathway in the mechanism of BJPC for treating asthma.

Conclusions: BJPC plays an anti-inflammation role in asthma, which might be a promising therapy through mediating primary bile acid biosynthesis.

References
1.
Tuo H, Ren Y, Wang Z, Cheng X, Liu X, Li R . [Effects of VOR on asthmatic BALB/c mice and on immune-activity of Th17 cells]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2018; 32(2):137-141. DOI: 10.13459/j.cnki.cjap.2016.02.011. View

2.
Huang W, Lee S, Oh S, Yoon H, Pan J, Jeong I . Pod Extract Mitigates Ovalbumin-Induced Asthma Onset in Male BALB/c Mice via Suppression of MAPK. Molecules. 2022; 27(19). PMC: 9573573. DOI: 10.3390/molecules27196317. View

3.
Zhang X, Zhu X, Wang C, Zhang H, Cai Z . Non-targeted and targeted metabolomics approaches to diagnosing lung cancer and predicting patient prognosis. Oncotarget. 2016; 7(39):63437-63448. PMC: 5325375. DOI: 10.18632/oncotarget.11521. View

4.
Abdo M, Pedersen F, Kirsten A, Veith V, Biller H, Trinkmann F . Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma. J Allergy Clin Immunol Pract. 2022; 10(6):1545-1553.e2. DOI: 10.1016/j.jaip.2022.02.020. View

5.
An G, Wang W, Zhang X, Huang Q, Li Q, Chen S . Combined blockade of IL-25, IL-33 and TSLP mediates amplified inhibition of airway inflammation and remodelling in a murine model of asthma. Respirology. 2019; 25(6):603-612. DOI: 10.1111/resp.13711. View